In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances

@article{Vandeputte2020InVF,
  title={In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances},
  author={Marthe M Vandeputte and Annelies Cannaert and Christophe P. Stove},
  journal={Archives of Toxicology},
  year={2020},
  pages={1 - 12}
}
The landscape of new psychoactive substances (NPS) is constantly evolving, with new compounds entering the illicit drug market at a continuous pace. Of these, opioid NPS form a threat given their high potency and prevalence. Whereas previously, the use of fentanyl and fentanyl derivatives was the main point of attention, legislations have reacted accordingly, which may have been a driving force towards the (ab)use of alternative µ-opioid receptor (MOR) agonists. In contrast to fentanyl… 

Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays.

The µ-opioid receptor (MOR) affinity and activation potential was determined via [3H]-DAMGO binding in rat brain tissue homogenates, and was found to correlate well with different functional parameters.

A Vaccine against Benzimidazole-Derived New Psychoactive Substances That Are More Potent Than Fentanyl.

In this study, immunopharmacotherapy wherein antibodies are produced with high titers and nanomolar affinity to multiple benzimidazole-derived NPS opioids (BNO) is implemented, providing further insight into the in vivo effects of BNO drugs and the development of effective broad-spectrum therapeutics against NPS opioid substances.

U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market

The evidence demonstrates that U-47700 is a potent μ-opioid receptor agonist, which poses a serious risk for overdosing and death, however, most analogs of U- 47700 appear to be less potent and have been detected infrequently in forensic specimens.

First report on brorphine: the next opioid on the deadly new psychoactive substances' horizon?

This is the first report on the identification and full chemical characterization of brorphine, a novel potent synthetic opioid with a piperidine benzimidazolone structure that poses a serious and imminent health threat for any user.

Antinociceptive and Discriminative Stimulus Effects of Six Novel Psychoactive Opioid Substances in Male Rats

The data suggest the four synthetic opioids possess similar abuse liability risks as typical opioid agonists, and butyryl fentanyl, acetyl fentanyl, AH-7941, and MT-45 have abuse liability like other opioids agonists.

Toxicological and pharmacological characterization of novel cinnamylpiperazine synthetic opioids in humans and in vitro including 2-methyl AP-237 and AP-238.

The in vitro MOR activation potential of the studied cinnamylpiperazines was lower than that of fentanyl and other novel synthetic opioids (NSOs), in line with the relatively higher concentrations observed in postmortem toxicology samples-an important observational link between in vitro pharmacology and in vivo toxicology.

Blood concentrations of new synthetic opioids

Blood levels of new opioids are extremely difficult to interpret as their high potency creates a risk of respiratory depression even at low doses, which makes it impossible to define concentration ranges, especially the minimum fatal concentrations.

References

SHOWING 1-10 OF 107 REFERENCES

Opioids in the Frame of New Psychoactive Substances Network: A Complex Pharmacological and Toxicological Issue.

Fentanyl analogues are among the most frequently abused and pose several clinical concerns and therefore will be thoroughly discussed in this systematic review of new psychoactive substances NPS.

The search for the “next” euphoric non-fentanil novel synthetic opioids on the illicit drugs market: current status and horizon scanning

Pre-emptive research on the most likely compounds to emerge next is recommended, so providing drug metabolism and pharmacokinetic data to ensure that new substances are detected early in toxicological samples is recommended.

First report on brorphine: the next opioid on the deadly new psychoactive substances' horizon?

This is the first report on the identification and full chemical characterization of brorphine, a novel potent synthetic opioid with a piperidine benzimidazolone structure that poses a serious and imminent health threat for any user.

Activity-Based Concept to Screen Biological Matrices for Opiates and (Synthetic) Opioids.

Although the cooccurrence of opioid antagonists is currently a limitation, the bioassay's high detection capability, specificity, and untargeted nature may render it a useful first-line screening tool to investigate potential opioid intoxications.

Novel synthetic opioids: A review of the literature

Activation of μ opioid receptors by MT-45 and its fluorinated derivatives.

F fluorinated derivatives of MT-45 are potent μ receptor agonists and this may pose a danger to illicit opioid users and inhibition of NMDA receptors by a metabolite ofMT-45 may contribute to the reported dissociative effects.

In vitro activity-profiling of Cumyl-PEGACLONE variants at the CB1 receptor: fluorination versus isomer exploration.

It is demonstrated that 5-fluorination of Cumyl-PEGACLONE is not linked to an intrinsically higher CB1 activation potential, and that the ethylbenzyl and n-propylphenyl isomers yield a strongly reduced CB1 activitation.
...